Back to Results
First PageMeta Content
Tropical diseases / Zoonoses / Immune system / Mononegavirales / Ebola virus disease / Immunoglobulin G / Antibody / Passive immunity / Marburg virus disease / Biology / Medicine / Microbiology


Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease John M. Dye1,2, Andrew S. Herbert, Ana I. Kuehne, James F. Barth, Majidat A. Muhammad, Samantha E. Zak, Ramon A. Ortiz, Laura I. Prugar
Add to Reading List

Document Date: 2012-04-18 15:31:20

Open Document

File Size: 640,73 KB

Share Result on Facebook

City

Tempe / /

Company

IgG / Potryvaeva NV / J.M.D. A.S. / /

Country

Sudan / Congo / Guinea / Angola / Liberia / /

/

Facility

Laboratory Animal Care International / US Army Medical Research Institute of Infectious Diseases / Arizona State University / Laboratory Animals / Albert Einstein College of Medicine / University of Maryland / US Army Medical Research Institute / /

IndustryTerm

shared structural solution / infection site / animal protocol / monoclonal antibody technologies / established technologies / /

MedicalCondition

vesicular stomatitis / Ebola virus infection / viral infection / lethal infection / Argentine haemorrhagic fever / passive antibody polyclonal antibody hemorrhagic fever virus / Thrombocytopenia / experimental Ebola virus infections / low level viremia / deadliest infectious agents / Sudan Ebola / recombinant vesicular stomatitis virus / hemorrhagic fever virus infection / lymphopenia / natural human infection / Ebola infection / illness / infections / detectable viremia / hemorrhagic fever / haemorrhagic fever / disease / Ebola / pose significant emerging disease / recombinant vesicular stomatitis / Marburg virus infection / MARV recombinant vesicular stomatitis / hypothermia / lethal Ebola / Fever / MARV infection / viremia / EBOV infection / Marburg virus Angola infection / NHPs showing thrombocytopenia / initial infection / virus infection / lethal Ebola virus infection / infection / depression / rash / frequently fatal hemorrhagic fever / /

MedicalTreatment

passive immunotherapy / passive immunization / vaccination / Immunotherapy / sham treatment / blood transfusions / antibody therapy / /

MusicGroup

A.I. / /

Organization

Harvard Medical School / International Scientific and Technical Committee / World Health Organization / Food and Drug Administration / University of Maryland / USAMRIID Institutional Animal Care and Use Committee / Association for the Assessment and Accreditation of Laboratory Animal Care International / US Army Medical Research Institute for Infectious Diseases / Health Organization / US Army Medical Research Institute of Infectious Diseases / Arizona State University / United States Army / Albert Einstein College of Medicine / European Union / William D. Pratt1 Division of Virology / /

Person

Ana I. Kuehne / Brian Hannah / Arch Virol / Alan Schmaljohn / Andrew S. Herbert / Keith Reimann / James F. Barth / Ramon A. Ortiz / Laura I. Prugar / Mike Winpigler / Gene Olinger / Samantha E. Zak / Jimmy Fiallos / Arch Virol Suppl / Josh Moore / Steven Bradfute / Jay Wells / Frederick / /

Position

prearranged editor / Oswald WB / Author / VP / et al. / Krasnianskiĭ VP / Fisher / /

ProvinceOrState

Maryland / Arizona / /

RadioStation

Briggiler AM / /

Region

sub-Saharan Africa / /

Technology

radiation / animal protocol / siRNA / antibodies / monoclonal antibody technologies / /

URL

www.pnas.org/cgi/doi/10.1073/pnas.1200409109 / www.pnas.org/lookup/suppl/doi / /

SocialTag